MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 260 filers reported holding MYRIAD GENETICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,106,000 | -43.1% | 39,803 | -32.0% | 0.01% | -45.5% |
Q1 2019 | $1,945,000 | +1.6% | 58,573 | -11.1% | 0.01% | -8.3% |
Q4 2018 | $1,914,000 | -30.0% | 65,853 | +10.8% | 0.01% | -14.3% |
Q3 2018 | $2,733,000 | +317.9% | 59,408 | +239.5% | 0.01% | +250.0% |
Q2 2018 | $654,000 | -14.5% | 17,500 | -32.4% | 0.00% | 0.0% |
Q1 2018 | $765,000 | +280.6% | 25,890 | +343.3% | 0.00% | +300.0% |
Q4 2017 | $201,000 | -47.0% | 5,840 | -67.6% | 0.00% | -75.0% |
Q4 2013 | $379,000 | – | 18,041 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |